Two Sigma Advisers
PRCT icon

Two Sigma Advisers’s Procept Biorobotics PRCT Stock Holding History

Two Sigma Advisers’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,499
Closed -$1.24M – 1611
2025
Q4 		$1.24M Buy
+39,499
New +$1.31M ﹤0.01% 1383
2025
Q3 		– Sell
-87,400
Closed -$5.03M – 2573
2025
Q2 		$5.03M Sell
87,400
-28,100
-24% -$1.59M 0.01% 737
2025
Q1 		$6.73M Buy
115,500
+25,500
+28% +$1.74M 0.02% 668
2024
Q4 		$7.25M Buy
90,000
+63,300
+237% +$5.41M 0.02% 576
2024
Q3 		$2.14M Sell
26,700
-28,100
-51% -$2M 0.01% 1028
2024
Q2 		$3.35M Sell
54,800
-38,600
-41% -$2.3M 0.01% 933
2024
Q1 		$4.62M Buy
+93,400
New +$4.45M 0.01% 816

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Advisers's PRCT Position: Q1 2026 in Review

Two Sigma Advisers sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 39,499 shares — an estimated $1.24M sold.

Two Sigma Advisers first reported a position in PRCT in Q1 2024 and held it in 7 quarters. The position peaked at $7.25M in Q4 2024. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Two Sigma Advisers reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 39,499 Procept Biorobotics shares in Q1 2026, an estimated $1.24M.
  • Two Sigma Advisers first reported a position in Procept Biorobotics in Q1 2024 and held it in 7 quarters.
  • Two Sigma Advisers's Procept Biorobotics position peaked at $7.25M in Q4 2024.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.